Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04364620
Title AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alethia Biotherapeutics

lung non-small cell carcinoma


AB-16B5 + Docetaxel

Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.